US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi U.S. Biotech 2x Daily ETF

34.21

-0.1504-0.44%

Post-market: 34.950.7361+2.15%16:10 EDT

Volume:15.63K

Turnover:546.62K

Market Cap:513.21K

PE:- -

High:34.99

Open:34.99

Low:34.21

Close:34.36

52wk High:42.22

52wk Low:25.26

Shares:15.00K

Float Shares:15.00K

Volume Ratio:5.10

T/O Rate:104.17%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

BICO folds Cellenion into SCIENION to sharpen precision biotech focus

Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase

Mizuho biotech analysts hold an analyst/industry conference call

JPMorgan SMid biotech analysts hold an analyst/industry conference call

RYUK-IL C&S pivots to biotech and pet markets with sweeping charter changes

Citi Downgrades Moderna Stock after 222% Rally, Calls Oncology Expectations “Unrealistic”

3 Australian Biotech Stocks With Up To 77% Fair Value Upside

Simply Wall St.

New Grades, Price Targets for the Top-3 Stocks in the Market’s Hottest Sector

Invivyd Phase 3 COVID Antibody Trial Shows Superior Safety

GT Biopharma Regains Nasdaq Minimum Bid Compliance

VOOLT boosts deeptech portfolio with discounted stake in cancer vaccine developer Vaxican

Arterra Bioscience Secures €2 Million Backing for NEX-BIO Biotech Expansion

Enlivex Drops RAIN-Token Financing Deal, Halts Planned Private Placement

Why Is Moderna Stock (MRNA) Soaring Today, September 21?

William Blair biotech analyst holds an analyst/industry conference call

Oncopeptides to Present New Pepaxti Data at Key Myeloma Meeting

Wedbush biotech analyst holds an analyst/industry conference call

Asep Medical Settles $288,500 in Debt Through Share Issuance

Rakovina Therapeutics Adds Yale DNA Repair Expert to Scientific Advisory Board

TME Pharma CEO Emphasizes Cash Discipline and Strategic Partnering for Lead Cancer Asset

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/XBIX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XBIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBIX\",,,,,undefined,":{"symbol":"XBIX","market":"US","secType":"STK","nameCN":"Corgi U.S. Biotech 2x Daily ETF","latestPrice":34.2139,"timestamp":1790971200000,"preClose":34.3643,"halted":0,"volume":15626,"hourTrading":{"tag":"盘后","latestPrice":34.95,"preClose":34.2139,"latestTime":"16:10 EDT","volume":4,"amount":136.8556,"timestamp":1790971805190,"change":0.7361,"changeRate":0.021515,"amplitude":0},"delay":0,"changeRate":-0.00437663505440232,"floatShares":15000,"shares":15000,"eps":0,"marketStatus":"Market Closed","change":-0.1504,"latestTime":"10-02 16:00:00 EDT","open":34.99,"high":34.99,"low":34.2139,"amount":546621,"amplitude":0.022584,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"CBOE","adjPreClose":34.3643,"nav":34.28,"aum":514200,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":34.95,"preClose":34.2139,"latestTime":"16:10 EDT","volume":4,"amount":136.8556,"timestamp":1790971805190,"change":0.7361,"changeRate":0.021515,"amplitude":0},"volumeRatio":5.104867656943041},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBIX\",,,,,undefined,":{"symbol":"XBIX","floatShares":15000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":5.104867656943041,"shares":15000,"dividePrice":0,"high":34.99,"amplitude":0.022584,"preClose":34.3643,"low":34.2139,"week52Low":25.2639,"pbRate":"--","week52High":42.2188,"institutionHeld":0,"latestPrice":34.2139,"eps":0,"divideRate":0,"volume":15626,"delay":0,"ttmEps":0,"open":34.99,"prevYearClose":25.42,"prevWeekClose":34.6603,"prevMonthClose":35.9112,"prevQuarterClose":35.9112,"fiveDayClose":34.6603,"twentyDayClose":39.3866,"sixtyDayClose":40.627},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBIX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBIX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBIX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672991794","title":"BICO folds Cellenion into SCIENION to sharpen precision biotech focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2672991794","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672991794?lang=en_us&edition=fundamental","pubTime":"2026-10-02 13:32","pubTimestamp":1790919176,"startTime":"0","endTime":"0","summary":"BICO Group AB Class B ( ($SE:BICO) ) has issued an announcement. BICO Group AB has completed the integration of single-cell specialist Cellenion in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bico-folds-cellenion-into-scienion-to-sharpen-precision-biotech-focus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bico-folds-cellenion-into-scienion-to-sharpen-precision-biotech-focus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0499858602.USD","LU1242518857.USD","BK4554","LU0289960550.SGD","SG9999013478.USD","LU0251143029.SGD","BK4220","LU0737861269.HKD","LU1861217088.USD","LU1861220207.SGD","LU0516422952.EUR","SG9999014484.SGD","IE0034224299.USD","LU2065171311.SGD","BK4588","LU0210637038.USD","BK4551","LU0532188223.SGD","LU2360107671.USD","BK4581","BK4085","LU2008162690.USD","NVIB","LU0048573645.USD","LU0345775950.USD","SE","SG9999013460.SGD","LU2152927971.USD","LU0441851309.USD","LU0572940350.SGD","LU2177674079.SGD","LU0589944569.HKD","BK4585","SG9999002620.SGD","LU0175139822.USD","LU0499858438.USD","SGXZ58947870.SGD","SG9999013486.USD","FDNI","SG9999006266.SGD","XBIX","LU0072462343.USD","BK4503","LU0516422440.USD","SG9999005177.SGD","LU0261945553.USD","LU2125910849.SGD","LU2543165471.USD","SG9999002406.SGD","LU0516423174.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672629967","title":"Nanobiotix taps veteran biotech CFO Arnd Christ to steer next growth phase","url":"https://stock-news.laohu8.com/highlight/detail?id=2672629967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672629967?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:37","pubTimestamp":1790887025,"startTime":"0","endTime":"0","summary":"The latest update is out from Nanobiotix ( ($FR:NANO) ). Nanobiotix is a late‑stage French biotechnology company developing physics‑based therapeut...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanobiotix-taps-veteran-biotech-cfo-arnd-christ-to-steer-next-growth-phase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RSPH","XT","FWD","LNGR","BK4585","NVIB","BK4588","BBP","FHLC","JDOC","NANO","DARP","IBB","IEIH","SYNB","AGNG","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672761479","title":"Mizuho biotech analysts hold an analyst/industry conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2672761479","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672761479?lang=en_us&edition=fundamental","pubTime":"2026-10-02 03:00","pubTimestamp":1790881217,"startTime":"0","endTime":"0","summary":"Biotech AnaLyst Syed, along with the Biotech Research Team, discuss Vaxcyte (PCVX), ahead of VAX-31 Ph3 OPUS-1 readout this October, as well as BBI...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mizuho-biotech-analysts-hold-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mizuho-biotech-analysts-hold-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","XBI","IE0009354923.USD","BK4581","BK4585","PCVX","BK4588","XBIX","LU0053671581.USD","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672662237","title":"JPMorgan SMid biotech analysts hold an analyst/industry conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2672662237","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672662237?lang=en_us&edition=fundamental","pubTime":"2026-10-02 00:50","pubTimestamp":1790873411,"startTime":"0","endTime":"0","summary":"SMid Biotechnology Analysts Cheng and Medeiros discuss their view on Kymera Therapeutics’s (KYMR) STATS readout in atopic dermatitis on an Analyst/...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jpmorgan-smid-biotech-analysts-hold-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jpmorgan-smid-biotech-analysts-hold-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BZ1G4Q59.USD","JPMO","NVIB","XLF","XBIX","LU0971096721.USD","LU0943347566.SGD","IYG","IYF","LU0265550946.USD","IE00B3S45H60.SGD","LU0320765489.SGD","KBWB","LU1917777945.USD","LU0820562030.AUD","JPM","LU0211326755.USD","LU0106831901.USD","LU0345769631.USD","TRUF","LU2505996509.AUD","IXG","UYG","FTXO","LU2168563687.JPY","LU2168564222.USD","LU1244550577.SGD","LU2357627491.SGD","JPO","LU2054465674.USD","LU1064131342.USD","IE000BZT7R73.USD","BK4139","LU2552382132.HKD","IE00BJTD4V19.USD","LU0256863902.USD","IE00BFXG1179.USD","PGF","TFNS","VFH","SG9999002224.SGD","KYMR","LU0234572021.USD","FNCL","BK4207","LU2236285917.USD","IE00BN8TJ469.HKD","LU2213496289.HKD","BK4585","LU0238689110.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672739201","title":"RYUK-IL C&S pivots to biotech and pet markets with sweeping charter changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2672739201","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672739201?lang=en_us&edition=fundamental","pubTime":"2026-10-01 11:12","pubTimestamp":1790824358,"startTime":"0","endTime":"0","summary":"RYUK-IL C&S., Ltd. ( ($KR:191410) ) has provided an announcement. RYUK-IL C&S., Ltd. shareholders approved a partial amendment of the Articles of I...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ryuk-il-cs-pivots-to-biotech-and-pet-markets-with-sweeping-charter-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ryuk-il-cs-pivots-to-biotech-and-pet-markets-with-sweeping-charter-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671206085","title":"Citi Downgrades Moderna Stock after 222% Rally, Calls Oncology Expectations “Unrealistic”","url":"https://stock-news.laohu8.com/highlight/detail?id=2671206085","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671206085?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:15","pubTimestamp":1790766915,"startTime":"0","endTime":"0","summary":"Citigroup downgraded Moderna, Inc. ($MRNA) from Neutral/High Risk to Sell/High Risk after the biotech stock’s sharp two-month rally, arguing that o...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/citi-downgrades-moderna-stock-after-222-rally-calls-oncology-expectations-unrealistic?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/citi-downgrades-moderna-stock-after-222-rally-calls-oncology-expectations-unrealistic?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","GNOM","BK4568","BK4534","BK4548","WDNA","MRNA","MRNY","BK4501","BK4588","BK4585","IDNA","BK4551","BK4532","NVIB","BK4533","BK4139","LGHT","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672738443","title":"3 Australian Biotech Stocks With Up To 77% Fair Value Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2672738443","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672738443?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:20","pubTimestamp":1790763656,"startTime":"0","endTime":"0","summary":"Australia’s inflation rate sitting at 4% and interest rates at a 15 year high of 4.6% are squeezing many growth stories. Yet that pressure also pushes investors toward companies with solid balance sheets and clear funding runways. That matters for Australian biotechnology stocks, where capital access can make or break a breakthrough. This article highlights three listed biotech opportunities screened for financial resilience and reasonable value.\nThe three biotech stocks covered below are a...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-vls/vita-life-sciences-shares/news/3-australian-biotech-stocks-with-up-to-77-fair-value-upside","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-vls/vita-life-sciences-shares/news/3-australian-biotech-stocks-with-up-to-77-fair-value-upside","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MYX.AU","BK4585","NVIB","XJO.AU","BBOZ.AU","XAO.AU","BK7096","BK4588","BK7067","CUV.AU","XKO.AU","XBI","GIVE.AU","BEAR.AU","BK4581","SLF.AU","GEAR.AU","IISV.AU","EIGA.AU","OZR.AU","QRE.AU","VLS.AU","E200.AU","IMLC.AU","BK7508","OZF.AU","VAS.AU","QFN.AU","IOZ.AU","ZYAU.AU","IIGF.AU","STW.AU","XBIX","VAP.AU","DACE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671117244","title":"New Grades, Price Targets for the Top-3 Stocks in the Market’s Hottest Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2671117244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671117244?lang=en_us&edition=fundamental","pubTime":"2026-09-30 02:43","pubTimestamp":1790707417,"startTime":"0","endTime":"0","summary":"How hot are biotech stocks? One of the bellwethers for the industry, the iShares Biotechnology ETF ($IBB) (left chart), has gained over 24% year to...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/new-grades-price-targets-for-the-top-3-stocks-in-the-markets-hottest-sector?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/new-grades-price-targets-for-the-top-3-stocks-in-the-markets-hottest-sector?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLK","PTH","BIS","JHMH","IBB","BK4550","BIOY","BK4585","BK4588","FBT","FXH","NVIB","RXL","XBIX","FDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671116862","title":"Invivyd Phase 3 COVID Antibody Trial Shows Superior Safety","url":"https://stock-news.laohu8.com/highlight/detail?id=2671116862","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671116862?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:49","pubTimestamp":1790682559,"startTime":"0","endTime":"0","summary":"The latest update is out from Invivyd ( ($IVVD) ). Invivyd, Inc. is a clinical-stage biotech company developing antiviral monoclonal antibodies, le...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/invivyd-phase-3-covid-antibody-trial-shows-superior-safety?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/invivyd-phase-3-covid-antibody-trial-shows-superior-safety?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","XBIX","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670553422","title":"GT Biopharma Regains Nasdaq Minimum Bid Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2670553422","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670553422?lang=en_us&edition=fundamental","pubTime":"2026-09-26 04:54","pubTimestamp":1790369640,"startTime":"0","endTime":"0","summary":"GT Biopharma ( ($GTBP) ) has provided an announcement. GT Biopharma, Inc., a Nasdaq-listed biotech company, had fallen out of compliance with the e...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gt-biopharma-regains-nasdaq-minimum-bid-compliance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gt-biopharma-regains-nasdaq-minimum-bid-compliance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4119","GT","XBIX","BK4588","NVIB","LCLG","NQmain","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669110098","title":"VOOLT boosts deeptech portfolio with discounted stake in cancer vaccine developer Vaxican","url":"https://stock-news.laohu8.com/highlight/detail?id=2669110098","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669110098?lang=en_us&edition=fundamental","pubTime":"2026-09-23 18:47","pubTimestamp":1790160467,"startTime":"0","endTime":"0","summary":"An announcement from VOOLT Spolka Akcyjna ( ($PL:VLT) ) is now available. VOOLT S.A. has increased its stake in Polish biotech spin-off Vaxican sp....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/voolt-boosts-deeptech-portfolio-with-discounted-stake-in-cancer-vaccine-developer-vaxican?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/voolt-boosts-deeptech-portfolio-with-discounted-stake-in-cancer-vaccine-developer-vaxican?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","VLT","XBIX","EVNT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669556124","title":"Arterra Bioscience Secures €2 Million Backing for NEX-BIO Biotech Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2669556124","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669556124?lang=en_us&edition=fundamental","pubTime":"2026-09-23 03:02","pubTimestamp":1790103749,"startTime":"0","endTime":"0","summary":"The latest update is out from Arterra Bioscience SpA ( ($IT:ARBS) ). Arterra Bioscience S.p.A., a Naples-based green biotech group listed on Eurone...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arterra-bioscience-secures-e2-million-backing-for-nex-bio-biotech-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arterra-bioscience-secures-e2-million-backing-for-nex-bio-biotech-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4581","XBIX","BK4585","BK4139","NVIB","XBI","IOBT","VGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669314478","title":"Enlivex Drops RAIN-Token Financing Deal, Halts Planned Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669314478","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669314478?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:27","pubTimestamp":1790080047,"startTime":"0","endTime":"0","summary":"An announcement from Enlivex ( ($ENLV) ) is now available. Enlivex Ltd., a Nasdaq-listed longevity-focused biotech, is developing Allocetra™, an ad...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/enlivex-drops-rain-token-financing-deal-halts-planned-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/enlivex-drops-rain-token-financing-deal-halts-planned-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","NVIB","LCLG","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669160402","title":"Why Is Moderna Stock (MRNA) Soaring Today, September 21?","url":"https://stock-news.laohu8.com/highlight/detail?id=2669160402","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669160402?lang=en_us&edition=fundamental","pubTime":"2026-09-22 02:54","pubTimestamp":1790016874,"startTime":"0","endTime":"0","summary":"Moderna shares ($MRNA) surged by more than 14% to about $176 on Monday afternoon. This came after the U.S. pharma and biotech firm announced a key ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-moderna-stock-mrna-soaring-today-september-12?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-moderna-stock-mrna-soaring-today-september-12?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","BK4501","BK4534","NVIB","BK4568","BK4551","WDNA","IDNA","BK4532","BK4533","MRNY","BK4585","BK4139","XBIX","LGHT","BK4588","GNOM","MRNA","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669253162","title":"William Blair biotech analyst holds an analyst/industry conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2669253162","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669253162?lang=en_us&edition=fundamental","pubTime":"2026-09-22 00:35","pubTimestamp":1790008535,"startTime":"0","endTime":"0","summary":"Biotech Analyst Minter, along with Ross Summer, MD, discuss updates in idiopathic pulmonary fibrosis ahead of IPF summit conference and expected AL...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/william-blair-biotech-analyst-holds-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/william-blair-biotech-analyst-holds-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4581","BK4588","XBIX","XBI","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669164926","title":"Oncopeptides to Present New Pepaxti Data at Key Myeloma Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2669164926","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669164926?lang=en_us&edition=fundamental","pubTime":"2026-09-21 23:32","pubTimestamp":1790004777,"startTime":"0","endTime":"0","summary":"Oncopeptides AB ( ($SE:ONCO) ) has provided an update. Oncopeptides AB, a Stockholm-listed biotech focused on hard-to-treat cancers, is using its p...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oncopeptides-to-present-new-pepaxti-data-at-key-myeloma-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oncopeptides-to-present-new-pepaxti-data-at-key-myeloma-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0516422366.SGD","LU0048573645.USD","LU0345776255.USD","LU1861217088.USD","IE0001KFT4U8.USD","LU0516423091.SGD","BK4585","LU1242518857.USD","LU0289960550.SGD","LU0499858438.USD","LU2360107671.USD","SG9999014492.USD","BK4588","SG9999014484.SGD","SGXZ58947870.SGD","BK4566","LU0251143029.SGD","LU0572939691.SGD","NVIB","LU1048588211.SGD","LU2238330802.EUR","SG9999001135.SGD","BK4220","BK4551","BK4548","LU2065171311.SGD","LU2125910500.SGD","XBIX","BK4535","SE","LU0532188223.SGD","LU0823038988.USD","LU2065170008.USD","SG9999013460.SGD","LU1861220207.SGD","LU2152927971.USD","LU0737861269.HKD","LU0516422440.USD","IE00BD6J9T35.USD","LU2543165471.USD","LU2177674079.SGD","LU0516423174.USD","LU1839390173.USD","SG9999002679.SGD","FDNI","LU1770036033.HKD","LU1242518931.SGD","LU0175139822.USD","LU0210637038.USD","LU0572940350.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669110169","title":"Wedbush biotech analyst holds an analyst/industry conference call","url":"https://stock-news.laohu8.com/highlight/detail?id=2669110169","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669110169?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:55","pubTimestamp":1789998926,"startTime":"0","endTime":"0","summary":"Biotech Analyst Zhong, along with Philip J. Mease, MD, of the University of Washington School of Medicine, discuss the positioning of emerging IL-1...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/wedbush-biotech-analyst-holds-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/wedbush-biotech-analyst-holds-an-analyst-industry-conference-call-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XBIX","BK4588","NVIB","BK4581","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668043976","title":"Asep Medical Settles $288,500 in Debt Through Share Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2668043976","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668043976?lang=en_us&edition=fundamental","pubTime":"2026-09-19 07:02","pubTimestamp":1789772544,"startTime":"0","endTime":"0","summary":"The latest update is out from ASEP Medical Holdings Inc ( ($TSE:ASEP) ). Asep Medical Holdings Inc., a biotech-focused investment issuer based in V...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/asep-medical-settles-288500-in-debt-through-share-issuance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/asep-medical-settles-288500-in-debt-through-share-issuance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668963402","title":"Rakovina Therapeutics Adds Yale DNA Repair Expert to Scientific Advisory Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2668963402","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668963402?lang=en_us&edition=fundamental","pubTime":"2026-09-17 17:32","pubTimestamp":1789637575,"startTime":"0","endTime":"0","summary":"Rakovina Therapeutics Inc ( ($TSE:RKV) ) just unveiled an announcement. Rakovina Therapeutics has appointed Yale physician-scientist and biotech en...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rakovina-therapeutics-adds-yale-dna-repair-expert-to-scientific-advisory-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rakovina-therapeutics-adds-yale-dna-repair-expert-to-scientific-advisory-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","BK4139","LENZ","BK4007","BK4539","NVIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667089246","title":"TME Pharma CEO Emphasizes Cash Discipline and Strategic Partnering for Lead Cancer Asset","url":"https://stock-news.laohu8.com/highlight/detail?id=2667089246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667089246?lang=en_us&edition=fundamental","pubTime":"2026-09-16 14:37","pubTimestamp":1789540665,"startTime":"0","endTime":"0","summary":"TME Pharma N.V. ( ($FR:ALTME) ) has provided an announcement. TME Pharma, a clinical-stage biotech group developing therapies for brain cancer and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tme-pharma-ceo-emphasizes-cash-discipline-and-strategic-partnering-for-lead-cancer-asset?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tme-pharma-ceo-emphasizes-cash-discipline-and-strategic-partnering-for-lead-cancer-asset?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0509642566.USD","LU1023057109.AUD","SG9999011746.SGD","BK4531","BK4571","IE00BYTNYN87.SGD","IE00BYQNZ168.SGD","BBC","NVIB","BK4108","LU0828238088.HKD","BK4509","BK4526","LU0359201612.USD","BK4535","TME","01698","LU0456842615.SGD","BK4563","DBB","BK4565","XBIX","LU0269904917.USD","IE00B12V2V27.USD","LU0359202008.SGD","LU2039709279.SGD","BK4552","BK4548"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":65,"code":"91000000","status":"200"}]}}